Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with acne have lower levels of a specific hormone marker than women without acne.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.

The study concluded that hirsutism is most common in women aged 14 to 48, often caused by PCOS, and can be effectively treated with Nd YAG laser and IPL.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Laser hair removal is effective for hirsutism when combined with treatment for the underlying causes.